Research & Innovation Information Centre
Tick (check) box to add article to PDF "basket"
An EU-funded researcher has helped define the core set of genes a cell needs to survive, advancing novel bioengineering approaches for bacteria and other microorganisms with applications in healthcare, food and nutrition.
Published: 31 August 2017
The EU-funded ABIOMATER project is developing new metamaterials with properties that can be changed remotely using a magnetic field. This could revolutionise biomedicine and biotechnology, particularly in the fields of optical devices, tissue engineering and regenerative medicine, to name but a few.
Published: 24 August 2017
How are cell identities created and maintained? How do cells develop? How do they respond to disease? EU-funded scientists are piecing together the puzzle tying certain proteins to DNA in an effort to stamp out cancer and other diseases.
Published: 22 August 2017
Shellfish are a significant source of food, yet we know very little about how they make their shells and how environmental factors affect them. The EU-funded CACHE project is finding out how shellfish produce their shells, how this production varies according to their environment, and what this means for the future of shellfish farming.
Published: 2 August 2017
Scientists are delving into the core machinery of cellular life, in search of the mechanisms driving bacterial evolution and adaptation. Their findings promise biosynthetic factories able to convert biomass into fuels and valuable chemicals.
Published: 7 April 2017
EU-funded researchers have demonstrated the feasibility of bioengineering microbial strains in a controlled manner, a fundamental scientific breakthrough that has significant potential for drug development and biotechnology. The project was also instrumental in establishing a new scientific discipline - xenobiology.
Published: 2 February 2017
Drugs derived from biological sources play a major role in modern healthcare, but producing them cost-effectively to keep up with rising demand is a major challenge for the pharmaceutical industry. EU-funded researchers are developing more efficient biopharmaceutical manufacturing processes that should expand patients' access to these highly effective therapies.
Published: 14 December 2016
For sufferers of primary immune deficiencies, every infection contracted could lead to a serious or debilitating illness. EU scientists have their sights set on a cure for the most severe forms of the disease's 200 variations, and have already had very positive results in clinical trials. The findings could also help treat other conditions.
Published: 28 November 2016
An ERC-funded project has significantly increased understanding of the crucial role that microorganisms in the gut play in maintaining health. The findings have since led to a patent, as well as a follow-on project that could one day steer the way to new targeted treatments for diseases, including cancer.
Published: 18 November 2016
For the first time ever, two ERC grantees, Prof. Luca G. Guidotti and Dr Matteo Iannacone, have observed in vivo how specific white blood cells, so-called cytotoxic T lymphocytes, identify, target and attack liver cells that are infected with the hepatitis B virus. To witness these immune cells in action in real time, the two scientists developed advanced, dynamic imaging techniques. An estimated 240 million people are chronically infected with hepatitis B worldwide.
Published: 28 July 2015